Exenatide extended-release; clinical trials, patient preference, and economic considerations

Sheila A DoggrellSchool of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, AustraliaAbstract: Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments being available. The revelation that insulin secretion is under the control of a...

Full description

Bibliographic Details
Main Author: Doggrell SA
Format: Article
Language:English
Published: Dove Medical Press 2013-01-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/exenatide-extended-release-clinical-trials-patient-preference-and-econ-a11907